You miss 100% of the shots you take (on WallStreetBets)
NERV
Minerva Neuroscie
Price Data Unavailable
About
Minerva Neuroscie
Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical development for Parkinson's disease.